Compile Data Set for Download or QSAR
maximum 50k data
Found 34 Enz. Inhib. hit(s) with all data for entry = 10466
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489612(1-(4-(4-amino-8- fluoro-6,7-dimethoxy- quinazolin-...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489650(4-((2S,4R)-1-((5- methoxy-7-methyl- 1H-indol-4-yl)...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489648((4-((2S,4R)-1-((5- methoxy-7-methyl- 1H-indol-4-yl...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489646((R)-imino(4-((2S,4R)- 1-((5-methoxy-7- methyl-1H-i...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489645((S)-imino(4-((2S,4R)- 1-((5-methoxy-7- methyl-1H-i...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489644((4-((2S,4R)-1-((5- methoxy-7-methyl- 1H-indol-4-yl...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489643(4-(1-((5-methoxy-7- methyl-1H-indol- 4-yl)methyl)-...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489642(N-hydroxy-4-(1-((5- methoxy-7-methyl- 1H-indol-4-y...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489641((4-(1-((5-methoxy-7- methyl-1H-indol-4- yl)methyl)...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489640(US10961252, Cmp No. 25 | US11248000, Cmp No. 25 | ...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489636(US10961252, Cmp No. 22 | US11248000, Cmp No. 22 | ...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489631(1-(4-(4-amino-8-fluoro- 6,7-dimethoxy- quinazolin-...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489629((R)-4-(3-(4-(4-amino- 8-fluoro-6,7-dimethoxy- quin...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489628(4-((1R)-3-(8-(4-amino- 8-fIuoro-6,7-dimethoxy- qui...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489625((3R)-1-(8-(4-amino- 8-fluoro-6,7- dimethoxyquinazo...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489623((3R)-1-(4-(4-amino- 8-fluoro-6,7- dimethoxyquinazo...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489613(1-(4-(4-amino-8- fluoro-6,7-dimethoxy- quinazolin-...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489614((R)-1-(4-(4-amino-8- fluoro-6,7-dimethoxy- quinazo...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489649((4-((2R,4S)-1-((5- methoxy-7-methyl- 1H-indol-4-yl...)
Affinity DataIC50:  5.50E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489616((R)-1-(4-(4-amino- 8-fluoro-6,7- dimethoxyquinazol...)
Affinity DataIC50:  5.50E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489617((R)-4-(4-amino-8- fluoro-6,7-dimethoxy- quinazolin...)
Affinity DataIC50:  5.50E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489622(4-(4-amino-8-fluoro- 6,7-dimethoxy- quinazolin-2-y...)
Affinity DataIC50:  5.50E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489624((R)-1-(4-(8-amino- 2,2,4-trifluoro- [1,3]dioxolo[4...)
Affinity DataIC50:  5.50E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489651(4-((2R,4R)-1-((5- methoxy-7-methyl- 1H-indol-4-yl)...)
Affinity DataIC50: >1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489634((1R,4s)-4-((S)-1-((5- methoxy-7-methyl- 1H-indol-4...)
Affinity DataIC50: >1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489632(4-(4,4-difluoro-1-((5- methoxy-7-methyl- 1H-indol-...)
Affinity DataIC50: >1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489619((R)-4-(4-amino-8- fluoro-6,7-dimethoxy- quinazolin...)
Affinity DataIC50: >1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489618(4-(4-amino-8-fluoro- 6,7-dimethoxy- quinazolin-2-y...)
Affinity DataIC50: >1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489637(US10961252, Cmp No. 23 | US11248000, Cmp No. 23 | ...)
Affinity DataIC50: >1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489635(4-((2S,4R)-1-((5- methoxy-7-methyl- 1H-indazol-4-y...)
Affinity DataIC50: >1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489626(1-(3-(4-amino-8- fluoro-6,7-dimethoxy- quinazolin-...)
Affinity DataIC50: >1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489627((3R)-1-(5-(4-amino- 8-fluoro-6,7- dimethoxyquinazo...)
Affinity DataIC50: >1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489611(1-(4-(4-amino-8- fluoro-6,7-dimethoxy- quinazolin-...)
Affinity DataIC50: >1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489638(4-((2S,4R)-1-((5- methoxy-2,7- dimethyl-1H-indol- ...)
Affinity DataIC50: >1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent